Recruitment of patients from diverse ethnic, racial, and socioeconomic backgrounds for clinical trials is desirable for both scientific and ethical reasons.
Participation rates in clinical trials are low for minorities and especially for black Americans.
This report summarizes the experience at Louisiana State University Medical Center in Shreveport, Louisiana, in enrolling black Americans in oncology treatment and prevention trials.
Barriers to enrollment are identified and discussed.
Although major strides must still be made in the area of cancer prevention, the university's experience demonstrates that black Americans can be encouraged to participate in and can be enrolled in cancer clinical trials.
Mots-clés Pascal : Essai clinique, Tumeur maligne, Epidémiologie, Minorité, Noir américain, Traitement, Louisiane, Etats Unis, Amérique du Nord, Amérique
Mots-clés Pascal anglais : Clinical trial, Malignant tumor, Epidemiology, Minority, Black American, Treatment, Louisiana, United States, North America, America
Notice produite par :
Inist-CNRS - Institut de l'Information Scientifique et Technique
Cote : 99-0148769
Code Inist : 002B04B. Création : 16/11/1999.